Pancreatic Cancer Research at Salk - Professor Ron Evans, Gene Expression Laboratory

November 16, 2020
Pancreatic cancer is a devastating disease with only 8% of patients surviving more than five years. Professor Ronald Evans shared clinical trial updates on pancreatic cancer research breakthroughs including immunotherapy and a Vitamin D derivative.